Soleus Capital Management »

Tyra Biosciences shares owned by Soleus Capital Management

Quarter-by-quarter ownership of Tyra Biosciences (TYRA) shares owned by Soleus Capital Management from 13F filings

Historical chart of Soleus Capital Management investment in Tyra Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Tyra Biosciences held by Soleus Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tyra Biosciences by Soleus Capital Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $3.3M 125k 26.29

More positions owned by Soleus Capital Management

Spdr Series Trust State Street Spd Put Option (XBI)
Krystal Biotech (KRYS)
Celcuity (CELC)
Novocure Ord Shs (NVCR)
Praxis Precision Medicines I Com New (PRAX)
Tg Therapeutics (TGTX)
Dex (DXCM)
BioMarin Pharmaceutical (BMRN)
Globus Med Cl A (GMED)
Beta Bionics (BBNX)
Amicus Therapeutics (FOLD)
Twist Bioscience Corp (TWST)
Organogenesis Hldgs (ORGO)
Syndax Pharmaceuticals (SNDX)
Mirum Pharmaceuticals (MIRM)

View all positions for Soleus Capital Management

Top funds holding Tyra Biosciences

RA Capital Management
Nextech Invest
Alta Partners Management Company
BVF
Commodore Capital
Canaan Partners XI
TCG Crossover Management
Henderson Group
Vestal Point Capital
BlackRock
Farallon Capital Management
Vanguard Group
Kynam Capital Management
5AM Venture Management
Caligan Partners

View all funds holding Tyra Biosciences